Patrick O'Donnell
Director/Board Member at CHITOGENX INC.
Net worth: - $ as of 2024-04-29
Profile
Patrick T.
O'Donnell is the founder of ProteoThera, Inc. He currently holds the position of President & Chief Executive Officer at HD Lifesciences LLC, is President, Chief Executive Officer & Director at NanoHive Medical LLC, and is an Independent Director at ChitogenX, Inc. In the past, he served as President, Chief Executive Officer & Director at Histogenics Corp., President & Chief Executive Officer at ProChon Biotech Ltd., Director-Global Marketing at Confluent Surgical, Inc., and EVP & GM-Commercial Operations at BONESUPPORT HOLDING AB.
He holds an MBA degree from Dominican University (Illinois) and an undergraduate degree from the University of Wisconsin.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CHITOGENX INC
-.--% | 2023-11-08 | 0 ( -.--% ) | - $ | 2024-04-29 |
Patrick O'Donnell active positions
Companies | Position | Start |
---|---|---|
CHITOGENX INC. | Director/Board Member | 2021-02-23 |
HD Lifesciences LLC | Chief Executive Officer | 2020-12-31 |
NanoHive Medical LLC
NanoHive Medical LLC Information Technology ServicesTechnology Services NanoHive Medical LLC is a leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company is based in Woburn, MA. The company's proprietary biomimetic Soft Titanium™ technology sets them apart in the $1.50B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration, all of which lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive was founded by Chris Jones and Ian Helmar, and the CEO is Patrick T. O'Donnell. | Chief Executive Officer | - |
Former positions of Patrick O'Donnell
Companies | Position | End |
---|---|---|
ProChon Biotech Ltd.
ProChon Biotech Ltd. Pharmaceuticals: MajorHealth Technology ProChon Biotech, Ltd. manufactures innovative growth factor-based therapies in regenerative medicine and orthopedics. The company was founded by Avner Yayon in 1995 and is headquartered in Tel Aviv, Israel. | Chief Executive Officer | 2011-04-30 |
Confluent Surgical, Inc.
Confluent Surgical, Inc. Medical SpecialtiesHealth Technology Confluent Surgical, Inc. designed and developed medical devices. The company was founded by Farhad Khosravi in August 1998 and was headquartered in Waltham, MA. | Sales & Marketing | - |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Chief Executive Officer | - |
BONESUPPORT HOLDING AB | Chief Operating Officer | - |
OCUGEN, INC. | President | 2013-06-09 |
Training of Patrick O'Donnell
Dominican University (Illinois) | Masters Business Admin |
University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BONESUPPORT HOLDING AB | Health Technology |
CHITOGENX INC. | Health Technology |
Private companies | 6 |
---|---|
Confluent Surgical, Inc.
Confluent Surgical, Inc. Medical SpecialtiesHealth Technology Confluent Surgical, Inc. designed and developed medical devices. The company was founded by Farhad Khosravi in August 1998 and was headquartered in Waltham, MA. | Health Technology |
Histogenics Corp.
Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
ProChon Biotech Ltd.
ProChon Biotech Ltd. Pharmaceuticals: MajorHealth Technology ProChon Biotech, Ltd. manufactures innovative growth factor-based therapies in regenerative medicine and orthopedics. The company was founded by Avner Yayon in 1995 and is headquartered in Tel Aviv, Israel. | Health Technology |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Health Technology |
HD Lifesciences LLC | |
NanoHive Medical LLC
NanoHive Medical LLC Information Technology ServicesTechnology Services NanoHive Medical LLC is a leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company is based in Woburn, MA. The company's proprietary biomimetic Soft Titanium™ technology sets them apart in the $1.50B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration, all of which lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive was founded by Chris Jones and Ian Helmar, and the CEO is Patrick T. O'Donnell. | Technology Services |
- Stock Market
- Insiders
- Patrick O'Donnell